Jeanny B. Aragon-Ching, MD, FACP, discusses how checkpoint inhibitors figure into the treatment algorithms for unresectable 1st line renal cell carcinoma (RCC) patients at Annual Meeting 2018.
How checkpoint inhibitors fit into RCC treatment algorithms
